CD38 and cardiac hypertrophy: Evidence suggests that a deficiency in CD38 significantly boosts intracellular nicotinamide adenine dinucleotide (NAD) levels across various tissues, curtails oxidative stress pathways, and ameliorates cardiac hypertrophy and myocardial fibrosis (33).